SILICON VALLEY, Calif. and BEIJING, June 1, 2026 /PRNewswire/ -- On May 29, 2026, Haisco Pharmaceutical Group Co., Ltd. ("Haisco") (Ticker Code: 002653) announced a licensing and research collaboration with Eli Lilly and Company ("Lilly") to develop innovative medicines across multiple...
Hence then, the article about haisco announces licensing and research collaboration agreement with lilly to develop innovative medicines across multiple therapeutic areas was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas )
Also on site :
- What ‘Legend of Zelda’ Superfan Jon Batiste Thinks of ‘Ocarina of Time’ Remake and the Game’s Iconic Score
- Could the US midterms further isolate Israel in Washington?
- Grimes to Star in the First-Ever AI-Generated Film Coming to Theaters: Watch a Clip